New York Genome Center

The New York Genome Center (NYGC) is an independent, nonprofit genome sequencing center and consortium of medical and research centers based in New York City. Its consortium members include Albert Einstein College of Medicine, Cold Spring Harbor Laboratory, Columbia University, Cornell University/Weill Cornell Medical College, The Jackson Laboratory, Memorial Sloan Kettering Cancer Center, Mount Sinai School of Medicine, NewYork-Presbyterian Hospital, New York University, North Shore LIJ, The Rockefeller University, and Stony Brook.[1][2][3] As of 2014, NYGC's technology collaborators include Illumina (the founding collaborator),[4] Life Technologies and BioNano Genomics.[5] In past years, technology collaborators have included Roche,[6] Sabey and GeneInsight.[4] In addition to its founding members, NYGC receives support from pharmaceutical, biotech, and life science companies, city and state funds, and a variety of foundations and individual donors.

NYGC began offering sequencing, bioinformatics, and data management services in February 2012 and expanded these services in mid-2012 through the launch of its pilot lab facilities at The Rockefeller University.[7] It is expanding its facilities at 101 Avenue of the Americas in Hudson Square.

In 2014, the Center purchased a HiSeq X Ten sequencing system to support US$1,000 per genome sequencing services.[8]

Mission statement

NYGC's stated mission is to "transform biomedical research and clinical care in New York and beyond through the creation of what will become one of the largest bioinformatics and genomics facilities in North America".[9] It aims to advance basic and translational life science research and to boost New York City as a biotech center.[10][11]

Leadership

NYGC's President and Scientific Director is neuro-oncologist and neuroscientist Robert Darnell.[12]

101 Avenue of the Americas Build-out

In July 2012, NYGC announced that it had signed a long-term lease for 170,000 square feet at 101 Avenue of the Americas.[7]

In addition to administrative offices, the $53 million facility build-out, which is expected to be completed by mid-2013, will include sequencing, bioinformatics, and research labs, a CLIA-certified laboratory to process clinical samples, and computing infrastructure to handle the processing and storage of large amounts of data.

The New York City Economic Development Corporation is providing NYGC with $5 million of low cost financing towards capital costs associated with the lease.[13][11]

See also

References

  1. ↑ "New York Genome Center Launches Unprecedented Collaboration of 11 Leading Medical/Research Institutions". Columbia University Medical Center. 3 November 2011. Archived from the original on 11 December 2013. Retrieved 10 March 2014.
  2. ↑ "Genome Center for Gotham". Bio-IT World (United States). 3 November 2011. ISSN 1538-5728. Archived from the original on 15 May 2013.
  3. ↑ Sirk, Kimberley (December 2011). "Start spreading the news". Drug Discovery News. Archived from the original on 10 March 2014. Retrieved 10 March 2014.
  4. ↑ 4.0 4.1 "Collaborators". New York Genome Center. Archived from the original on 30 May 2013.
  5. ↑ "Our Collaborators". New York Genome Center. Archived from the original on 14 February 2014. Retrieved 10 March 2014.
  6. ↑ "Collaborators". New York Genome Center. Archived from the original on 5 November 2011.
  7. ↑ 7.0 7.1 "Our History". New York Genome Center. July 2012. Archived from the original on 14 February 2014. Retrieved 10 March 2014.
  8. ↑ "News: Products & Services Deals". Gen. Eng. Biotechnol. News (paper) 34 (4). 15 February 2014. p. 12.
  9. ↑ "NYGC overview" (PDF). New York Genome Center. Retrieved 1 March 2013.
  10. ↑ "NY Genome Center Takes Big Biotech Catch-Up Step". Gen. Eng. Biotechnol. News. 1 August 2012. Archived from the original on 18 December 2013.
  11. ↑ 11.0 11.1 Philippidis, Alex (9 December 2011). "New Genome Center to Bring Sequencing, Bioinformatics Muscle to Big Apple". Gen. Eng. Biotechnol. News. Archived from the original on 19 December 2013.
  12. ↑ "Leadership". New York Genome Center. Archived from the original on 15 February 2014. Retrieved 10 March 2014.
  13. ↑ Geiger, Daniel (24 July 2012). "NY Genome Center Completes 170K S/F Deal". Commercial Observer. The New York Observer. Archived from the original on 19 July 2013. Retrieved 10 March 2014.

External links